Stock listing

SIX Swiss:SDZ Sandoz Group Ltd Aktie

Home listing (SIX Swiss) of Sandoz Group Ltd

Follow Sandoz Group Ltd into a list and get an email when it puts out news.

Share price · SIX:SDZ

80.50 CHF -1.00 (-1.2%)

Close on Nov 20, 2026

Past year +50.9% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
80.06 – 81.28 CHFNov 20, 2026
Volume
1.00M sharesNov 20, 2026
Market cap
34.83B CHFAt the close on Nov 20, 2026 · price × 432.7M shares outstanding
52-week range
52.54 – 86.90 CHFLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
95.38M CHFMedian day 941,541 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Sandoz Group Ltd logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
SIX Swiss:SDZ · Home80.50 CHF-1.00 (-1.2%)1,002,53080.8081.2880.0681.50Close on Nov 20, 2026
LSE:0SAN80.50 CHF-0.85 (-1.0%)29,35881.0081.2780.3081.35Close on Nov 20, 2026
OTC:SDZNY$95.00 USD-1.15 (-1.2%)11,954$95.90$96.13$94.61$96.15Close on Nov 20, 2026
Frankfurt:D8Y0€86.50 EUR0.00 (0.0%)—€85.50€86.50€85.50€86.50Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · SIX:SDZ · CHF, adjusted for splits

DayCloseChange%OpenHighLowVolume
80.50-1.00-1.2%80.8081.2880.061,002,530
81.50-1.50-1.8%83.1483.3281.081,084,682
83.00-1.60-1.9%84.2684.7082.96740,270
84.600.000.0%85.2685.9684.60800,095
84.60-2.30-2.6%86.7086.7084.60875,131
86.90+1.70+2.0%85.5086.9085.50594,035
85.20+1.82+2.2%83.4485.2083.42559,769
83.38-1.08-1.3%84.8085.0083.38641,485
84.46+0.68+0.8%84.0085.3284.00839,121
83.78+0.16+0.2%82.3283.7881.34893,546
83.62+1.48+1.8%82.7483.8082.26945,910
82.14-0.64-0.8%82.7083.0481.74953,426
82.78-0.08-0.1%82.3883.4281.78857,465
82.86+0.48+0.6%81.6282.9081.361,023,340
82.38-1.00-1.2%84.0084.2482.301,958,658
83.38+3.50+4.4%81.0085.6080.722,100,744
79.88-2.22-2.7%76.3681.3875.502,549,769
82.10-0.26-0.3%82.3083.3881.501,712,251
82.36+1.70+2.1%80.9683.2880.961,316,593
80.66+1.66+2.1%78.2481.1078.141,179,816
79.00+0.52+0.7%78.7879.4077.94849,811
78.48+1.36+1.8%76.8678.4876.52960,347
77.12+0.54+0.7%77.0077.8875.80873,851
76.58-0.60-0.8%77.0077.4676.361,228,199
77.18+1.92+2.6%75.5077.1874.721,177,371
75.26+1.44+2.0%73.8275.8073.641,217,432
73.82+2.18+3.0%71.4673.8271.18915,336
71.64+0.62+0.9%70.9672.6070.80790,576
71.02+1.30+1.9%70.2471.0269.72529,303
69.72+0.40+0.6%69.4870.5069.20789,191
69.32-1.42-2.0%70.5070.5069.20799,264
70.74+0.98+1.4%69.2271.1469.22876,464
69.76-0.24-0.3%70.7271.7068.241,270,044
70.00+1.48+2.2%69.0070.4268.121,035,480
68.52+0.10+0.1%67.8070.0266.881,000,473
68.42-2.44-3.4%69.8270.3468.421,125,443
70.86-1.14-1.6%72.7073.4670.42972,049
72.00+0.08+0.1%71.9873.5271.721,458,397
71.92+0.76+1.1%71.5272.3671.021,059,012
71.16+0.38+0.5%70.4871.2670.141,057,602
70.78-0.62-0.9%71.3672.6670.521,377,900
71.40+0.64+0.9%70.7672.0869.982,438,997
70.76+1.04+1.5%69.9071.3469.901,180,109
69.72+1.10+1.6%69.7670.3268.261,271,805
68.62+0.74+1.1%68.3470.4467.9217,326,209
67.88+2.16+3.3%66.3268.0466.141,518,295
65.72-0.06-0.1%65.5667.2665.361,457,343
65.78-0.72-1.1%66.0066.8065.50870,379
66.50-0.24-0.4%66.7068.1066.08791,630
66.74+0.68+1.0%66.0668.0065.68732,002
66.06-1.70-2.5%68.1868.3265.54822,548
67.76-0.44-0.6%67.8268.2066.42907,075
68.20-0.04-0.1%70.9071.7066.382,287,917
68.24-0.12-0.2%67.9468.5067.44569,824
68.36-2.00-2.8%70.2470.4468.34743,041
70.36+1.50+2.2%68.7670.7268.761,077,695
68.86-0.020.0%68.9669.4068.08926,220
68.88+0.96+1.4%68.1069.2067.62788,266
67.92-0.98-1.4%68.4468.5667.76995,657
68.90-1.64-2.3%71.2071.2068.48901,522
70.54-0.12-0.2%70.2071.4269.94691,672
70.66-2.88-3.9%73.0473.1870.66714,551
73.54+0.16+0.2%73.5873.8872.80624,593
73.38-0.46-0.6%73.4274.0072.50486,508
73.84+0.24+0.3%73.3474.2273.18660,105
73.60-0.50-0.7%74.5475.0073.06937,171
Ticker
SIX Swiss:SDZ
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
SIX Swiss
Currency
CHF

What changed lately

Latest news

Sandoz issues EUR 500 million bond

Sep 14, 2026

Closed 65.78 (-1.1%) on Sep 15, 2026

All Sandoz Group Ltd news

Sandoz Group Ltd on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
32 in the last 12 months · 50 in all · newest Nov 16, 2026 · oldest 2025
Calls
7 calls with a replay · 7 with a transcript · latest Aug 5, 2026
Decks
25 decks · latest Oct 28, 2026

Where Sandoz Group Ltd is listed

ListingExchangeCountryCurrency
SIX Swiss:SDZ · Home listing · This pageSIX SwissSwitzerlandCHF
LSE:0SANLSEUnited KingdomCHF
OTC:SDZNYOTCUnited StatesUSD
gettex:D8YgettexGermanyEUR
Lang & Schwarz:A3ETYBLang & SchwarzGermanyEUR
OTC:SDZXFOTCUnited StatesUSD
Tradegate:D8YTradegateGermanyEUR
Turquoise:SDZZTurquoiseUnited KingdomCHF
BX Swiss:D8YBX SwissSwitzerlandCHF
Aquis:SDZZAquisUnited KingdomCHF
gettex:D8Y0gettexGermanyEUR
LS Exchange:A3ETYBLS ExchangeGermanyEUR
VIE:SDZViennaAustriaEUR
BMV:SDZNBMVMexicoMXN
Frankfurt:D8YFrankfurtGermanyEUR
LS Exchange:A3EVQWLS ExchangeGermanyEUR
BIVA:SDZNBIVAMexicoMXN
Frankfurt:D8Y0FrankfurtGermanyEUR
Munich:D8YMunichGermanyEUR
Stuttgart:D8YStuttgartGermanyEUR
Dusseldorf:D8YDusseldorfGermanyEUR
Dusseldorf:D8Y0DusseldorfGermanyEUR
Hamburg:D8YHamburgGermanyEUR
Hamburg:D8Y0HamburgGermanyEUR
Lang & Schwarz:A3EVQWLang & SchwarzGermanyEUR
Munich:D8Y0MunichGermanyEUR
Stuttgart:D8Y0StuttgartGermanyEUR
Xetra:D8YXetraGermanyEUR
Hanover:D8YHanoverGermanyEUR

Valuation

P/E 43.3× against a median of 29.7×: 9th lowest of 11 Pharmaceuticals companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026

Enterprise value
39.00B CHF
P/E
43.3×
EV/sales
4.2×
EV/EBITDA
23.6×
Price/book
4.6×
Gross margin
47.4%
Operating margin
12.8%
Net margin
8.6%
Debt to equity
0.7×
Beta
No index for this market yet

Pharmaceuticals: the 10 companies nearest in size, of 492 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Sandoz Group Ltd · SIX:SDZUS$41.49BUS$46.45B43.3×4.2×23.6×4.6×8.6%0.7×n/a
argenx SE · EURONEXT:ARGXUS$58.86BUS$53.72B22.8×6.5×n/a7.0×31.4%0.0×n/a
Roche Holding Ltd · SIX:ROUS$51.16BUS$77.45B3.3×1.1×2.9×1.3×20.9%1.0×n/a
Sun Pharmaceutical Industries Limited · NSE:SUNPHARMAUS$48.80BUS$45.53B41.2×6.8×24.4×5.1×17.8%0.0×n/a
Teva Pharmaceutical Industries Limited · TASE:TEVAUS$46.34BUS$46.29B89.8×3.3×13.5×5.8×3.7%0.5×n/a
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A · SSE:600276US$44.90BUS$38.38B33.8×7.8×n/a4.5×27.0%0.0×n/a
Celltrion, Inc. · KRX:068270US$36.30BUS$35.65B30.8×9.7×25.9×2.7×32.2%0.0×n/a
Zoetis Inc. · NYSE:ZTSUS$32.69BUS$40.21B13.0×4.2×10.2×9.9×26.4%2.7×0.69
Divi's Laboratories Limited · NSE:DIVISLABUS$32.03BUS$32.03B101×26.4×74.8×17.7×26.1%0.0×n/a
Hansoh Pharmaceutical Group Company Limited · HKEX:3692US$23.77BUS$18.81B28.6×8.4×21.6×4.2×37.0%0.1×n/a
United Therapeutics Corporation · NASDAQ:UTHRUS$23.63BUS$21.56B19.2×6.8×15.2×3.8×38.6%0.0×0.46
Median of the othersUS$40.60BUS$39.29B29.7×6.8×18.4×4.8×26.7%0.0×0.57

Forecasts

Analysts' consensus from EODHD, read Nov 20, 2026. Not 6ix's view and not investment advice.

Price target
81.63 CHF · Analysts' mean
EPS, year to Dec 2026
4.18 · 16 analysts
Revenue, year to Dec 2026
11.98B · 10 analysts

Team and board

Officers

OfficerRole
Pascal BouyePresident, Generics Manufacturing & Supply
Leo BronfmanSenior VP, General Counsel North America
Craig MarksInvestor Relations
Katie FischerIR Coordinator
Silvia SiegfriedSenior Director, Investor Relations
Tamara HacklSenior Director, Investor Relations
David KamenirSenior VP, Strategy and Growth, North America
Elisa FiorelloSenior VP, People & Organization
Jeff BordenSenior VP, Supply Chain NA
Jonathan KimballSenior VP, US and Global Public Affairs
Len ArsenaultSenior VP, Scientific Affairs
Martin BickSenior VP, Market Access, Specialty Contracting, & Patient Services
Sébastien MénardSenior VP, Head of US Generics
Shannon BuhlSenior VP, Commercial Operations
Ted StueckSenior VP and Chief Ethics, Risk and Compliance Officer
Tom OcchipintiSenior VP, Head of US Biosimilar
Keren HaruviPresident North America
Kristen TilakSenior VP and Chief Financial Officer, North America

Board

DirectorRole
Yannis SkoufalosBoard member

Events

Next results
Feb 17, 2027 (expected)

Results days

QuarterResultsShare move
Q4 2025Dec 31, 2025−1.1%
Q2 2025Aug 7, 2025 · After close−6.4%
Q4 2024Mar 4, 2025−0.1%

Open Events

Decks

DeckKindSlidesDate
9M 2026 Earnings PresentationEarnings33 slidesOct 28, 2026
Investor Day (September 2026)Investor day120 slidesSep 8, 2026
Investor Day (2026)Investor day10 slidesSep 7, 2026
Investor Day (2026)Investor day10 slidesSep 7, 2026
Investor Day (2026)Investor day16 slidesSep 7, 2026
H1 2026 Earnings PresentationEarnings37 slidesAug 5, 2026
Q1 2026 Earnings PresentationEarnings28 slidesApr 29, 2026
FY 2025 Earnings PresentationEarnings42 slidesFeb 25, 2026
Investor Presentation (2026)Investor deck36 slidesFeb 24, 2026
J.P. Morgan Healthcare Conference 2026Conference31 slidesJanuary 2026
All 25 decks
DeckKindSlidesDate
Investor Presentation (2026)Investor deck43 slides2026
Q3 2025 Earnings PresentationEarnings36 slidesOct 30, 2025
H1 2025 Earnings PresentationEarnings40 slidesAug 7, 2025
H1 2025 Earnings PresentationEarnings35 slidesAugust 2025
Q1 2025 Earnings PresentationEarnings28 slidesApr 30, 2025
FY2024 Earnings PresentationEarnings41 slidesMar 5, 2025
Investor Presentation (February 2025)Investor deck32 slidesFebruary 2025
Q3 2024 Earnings PresentationEarnings29 slidesOct 30, 2024
H1 2024 Earnings PresentationEarnings33 slidesAug 8, 2024
Q1 2024 Earnings PresentationEarnings25 slidesMay 7, 2024
FY2023 Earnings PresentationEarnings37 slidesMar 13, 2024
J.P. Morgan Healthcare Conference 2024Conference25 slidesJan 9, 2024
9M 2023 Earnings PresentationEarnings23 slidesOct 24, 2023
Investor Day (June 2023)Investor day142 slidesJune 2023
Cowen Healthcare Conference 2015Conference23 slidesMar 4, 2015

Open Decks

Financings

RaiseDateIn US dollars
12-year 4.835% bond
Announced: €500M · Bank of America +5
Dealers: Bank of America (co-lead), Mizuho (co-lead), SEB (co-lead), Citi, HSBC, Société Générale
Use of proceeds: General corporate purposes including refinancing of existing debt
Sep 14, 2026US$577.36M
Dual-tranche CHF bonds
Closed: CHF 400M raised
Use of proceeds: Fully repay USD 750 million equivalent in USD and EUR term loans and extend debt maturities
Mar 31, 2025US$452.56M
Single-tranche EUR bond
Closed: €500M raised
Use of proceeds: Fully repay USD 750 million equivalent in USD and EUR term loans and extend debt maturities
Mar 31, 2025US$540.48M

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020
Revenue11.2B9.12B9.98B8.86B9.68B9.56B
Cost of revenue5.87B5.46B5.42B4.71B4.63B4.60B
Gross profit5.28B4.93B4.56B4.15B4.20B3.95B
Research and development1.10B958.0M926.0M795.6M831.1M866.6M
Selling, general and administrative2.53B2.41B379.7M22.5K
Operating income1.43B307.0M375.0M-22.5K1.49B1.42B
Depreciation and amortization545.0M502.0M525.0M456.6M484.0M687.9M
EBITDA1.97B809.0M900.0M456.6M1.98B2.11B
Interest expense220.0M235.1M202.0M84.0M64.3M73.5M
Income before tax1.21B-11.0M130.0M-22.5K1.30B700.9M
Income tax293.0M-12.0M50.0M361398.9M242.0M
Net income957.5M1.00M77.0M-22.9K828.4M409.0M
Earnings per share, basic2.190.000.18-0.001.920.95

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020
Cash and equivalents1.74B1.19B1.11B100.0K36.4M34.5M
Short-term investments-175.6M
Receivables2.77B3.15B2.63B3.23B2.99B2.63B
Inventory2.85B2.80B2.27B2.12B1.83B2.08B
Current assets8.16B7.80B6.37B5.98B5.07B4.99B
Property, plant and equipment2.78B1.99B1.85B1.90B1.93B2.08B
Goodwill8.01B7.47B6.39B7.44B7.68B7.00B
Total assets22.0B19.9B19.4B17.6B16.0B15.9B
Accounts payable1.85B1.52B1.59B1.10B923.9M833.6M
Current liabilities6.89B6.31B5.70B7.91B8.37B9.15B
Long-term debt4.70B4.39B3.98B30.0M
Total debt5.68B4.85B4.55B309.0M284.3M298.8M
Total liabilities12.6B11.7B10.8B8.80B8.55B9.04B
Shareholders' equity9.38B8.16B7.28B77.1K7.43B6.82B
Shares outstanding436.8M434.0M431.2M429.9M431.0M431.0M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020
Cash from operations1.59B656.0M362.0M1.22B1.24B1.03B
Capital spending-784.0M-596.0M-567.9M-407.8M-382.2M-309.7M
Free cash flow810.0M60.0M-242.6M760.2M855.8M720.9M
Cash from investing-980.0M-740.0M-614.0M-430.0M-631.8M-514.4M
Cash from financing-197.0M242.0M1.24B-769.0M-600.7M-513.4M
Dividends paid-315.0M-215.0M
Share buybacks0-12.0M0
Change in cash548.0M82.0M1.03B34.0M1.97M2.82M

Open Financials

Cap table

Built by 6ix from Sandoz Group Ltd’s releases · as of Sep 14, 2026

Common shares
432,692,617
Fully diluted
432,692,617

Fully diluted

LineShares
Common shares432,692,617

Share count over time

CountShares
Nov 22, 2026432,692,617

Open Cap table

Shareholders

Institutions

HolderSharesValueAs of
Ramirez Asset Management, Inc.120KUS$10.2MSep 30, 2026
Henry James International Management Inc.64,767US$5.5MSep 30, 2026
Confluence Investment Management LLC24,102US$2.04MSep 30, 2026
Delphi Management Inc15,777US$1.33MSep 30, 2026
Rhumbline Advisers10,124US$856KSep 30, 2026
Albert D Mason Inc6,542US$553KSep 30, 2026
Ferguson Wellman Capital Management, Inc3,362US$284KSep 30, 2026
O'Brien Greene & Co. Inc3,333US$282KSep 30, 2026
Mengis Capital Management, Inc.2,898US$245KSep 30, 2026
GAMMA Investing LLC1,544US$131KSep 30, 2026
All 28 holders
HolderSharesValueAs of
Mark Sheptoff Financial Planning, LLC764US$64,596Sep 30, 2026
PNC Financial Services Group, Inc.638US$53,943Sep 30, 2026
First Command Advisory Services, Inc.628US$53,097Sep 30, 2026
Calydon Capital545US$46,080Sep 30, 2026
Strengthening Families & Communities, LLC238US$20,198Sep 30, 2026
McMillan Office, Inc.213US$18,077Sep 30, 2026
Hantz Financial Services, Inc.138US$12,000Sep 30, 2026
Ascentis Independent Advisors66US$5,579Sep 30, 2026
United Community Bank60US$5,092Sep 30, 2026
Ascentis Wealth Management, LLC48US$4,057Sep 30, 2026
Essex Investment Management Co LLC47US$3,974Sep 30, 2026
Coston, McIsaac & Partners37US$3,128Sep 30, 2026
Compass Financial Management LLC35US$2,959Sep 30, 2026
Main Management ETF Advisors, LLC34US$3,000Sep 30, 2026
Archer Investment Corp32US$2,706Sep 30, 2026
Boyd Watterson Asset Management LLC32US$2,716Sep 30, 2026
Main Street Group, LTD12US$1,015Sep 30, 2026
Thurston, Springer, Miller, Herd & Titak, Inc.1US$84Sep 30, 2026

Register

HolderSharesOf the companyAs of
UBS Fund Management (Switzerland) AG27.4M6.4%Apr 30, 2024
The Capital Group Companies, Inc.23M5.2%Oct 28, 2026
BlackRock, Inc.21.1M4.9%Oct 4, 2023
Sandoz - Fondation de Famille17.9M4.1%Oct 4, 2023
Swisscanto Fondsleitung AGSep 18, 2026

Funds

HolderSharesValueAs of
Vanguard Total International Stock Index Fund6.11MUS$498MJul 31, 2026
MFS International Intrinsic Value Fund4.72MUS$396MMay 31, 2026
Vanguard Developed Markets Index Fund4.05MUS$366MJun 30, 2026
iShares Core MSCI EAFE ETF3.08MUS$251MJul 31, 2026
EUPAC Fund1.7MUS$154MJun 30, 2026
Fidelity International Index Fund1.57MUS$132MMay 31, 2026
iShares MSCI EAFE ETF1.47MUS$120MJul 31, 2026
Capital Income Builder1.21MUS$98.4MJul 31, 2026
International Core Equity 2 Portfolio1.17MUS$95.7MJul 31, 2026
Vanguard European Stock Index Fund993KUS$80.9MJul 31, 2026
Show 50 holders
HolderSharesValueAs of
Vanguard Ftse All-World Ex-Us Index Fund988KUS$80.5MJul 31, 2026
Schwab International Equity ETF914KUS$76.7MMay 31, 2026
International Dynamic Growth Fund868KUS$70.7MJul 31, 2026
Vanguard International Value Fund839KUS$68.4MJul 31, 2026
Fidelity Series Global ex U.S. Index Fund831KUS$67.6MJul 31, 2026
Disciplined Value International Fund741KUS$60.4MJul 31, 2026
Vanguard International Dividend Appreciation Index Fund720KUS$58.7MJul 31, 2026
Nuveen International Equity Index Fund681KUS$55.5MJul 31, 2026
iShares MSCI EAFE Growth ETF644KUS$52.5MJul 31, 2026
The Dfa International Value Series631KUS$51.4MJul 31, 2026
JOHCM International Select Fund629KUS$56.9MJun 30, 2026
Six Circles International Unconstrained Equity Fund594KUS$53.7MJun 30, 2026
iShares Core MSCI Total International Stock ETF576KUS$47MJul 31, 2026
State Street(R) SPDR(R) Portfolio Developed World ex-US ETF554KUS$50.2MJun 30, 2026
Dimensional International Value ETF509KUS$41.3MJul 31, 2026
MFS International Large Cap Value Fund507KUS$42.6MMay 31, 2026
Mercer Non-US Core Equity Fund491KUS$44.4MJun 30, 2026
iShares Core MSCI International Developed Markets ETF450KUS$36.6MJul 31, 2026
iShares MSCI Switzerland ETF392KUS$33MMay 31, 2026
Vanguard Total World Stock Index Fund362KUS$29.5MJul 31, 2026
Strategic Advisers International Fund346KUS$29.1MMay 31, 2026
Six Circles Managed Equity Portfolio International Unconstrained Fund335KUS$30.2MJun 30, 2026
Dimensional International Core Equity 2 ETF330KUS$26.8MJul 31, 2026
EQ/MFS International Intrinsic Value Portfolio295KUS$26.7MJun 30, 2026
MFS International Intrinsic Value Portfolio293KUS$26.5MJun 30, 2026
William Blair International Leaders Fund289KUS$26.1MJun 30, 2026
Invesco International Value Fund282KUS$23MJul 31, 2026
Schwab International Index Fund280KUS$22.9MJul 31, 2026
JPMorgan BetaBuilders Europe ETF277KUS$22.6MJul 31, 2026
iShares MSCI EAFE International Index Fund265KUS$23.9MJun 30, 2026
Variable Portfolio - Partners International Growth Fund262KUS$23.7MJun 30, 2026
Fidelity Total International Index Fund245KUS$19.9MJul 31, 2026
Schwab Fundamental International Equity ETF239KUS$20.1MMay 31, 2026
John Hancock Disciplined Value International Select ETF236KUS$21.4MJun 30, 2026
iShares Core MSCI Europe ETF234KUS$19.1MJul 31, 2026
Large Cap International Portfolio232KUS$18.9MJul 31, 2026
Fidelity Global ex U.S. Index Fund221KUS$18MJul 31, 2026
iShares Global Healthcare ETF220KUS$19.8MJun 30, 2026
Dimensional International Core Equity Market ETF210KUS$17MJul 31, 2026
Baillie Gifford International Alpha Fund203KUS$18.4MJun 30, 2026

This page holds 50 of 306 holders. Open Shareholders

Big stakes

StakeStakeSharesDateFiling
UBS Fund Management (Switzerland) AG6.36%27.4MApr 30, 2024SIX significant shareholder notification
The Capital Group Companies, Inc.5.28%23MOct 28, 2026SIX significant shareholder notification

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Craig MarksInvestor Relations · Since at least Apr 2, 2026
David KamenirSenior VP, Strategy and Growth, North America · Since at least Nov 5, 2026
Elisa FiorelloSenior VP, People & Organization · Since at least Nov 5, 2026
Glenn GereckePresident, Generics Manufacturing & Supply · Mar 10, 2026 – Nov 5, 2026 · Past
Jeff BordenSenior VP, Supply Chain NA · Since at least Nov 5, 2026
Jonathan KimballSenior VP, US and Global Public Affairs · Since at least Nov 5, 2026
Katie FischerIR Coordinator · Since at least Apr 2, 2026
Keren HaruviPresident North America · Since at least Aug 5, 2026
Kristen TilakSenior VP and Chief Financial Officer, North America · Since at least Nov 5, 2026
Len ArsenaultSenior VP, Scientific Affairs · Since at least Nov 5, 2026
All 20 people
PersonSeat
Leo BronfmanSenior VP, General Counsel North America · Since at least Nov 5, 2026
Martin BickSenior VP, Market Access, Specialty Contracting, & Patient Services · Since at least Nov 5, 2026
Pascal BouyePresident, Generics Manufacturing & Supply · Since at least Jul 15, 2026
Sébastien MénardSenior VP, Head of US Generics · Since at least Nov 5, 2026
Shannon BuhlSenior VP, Commercial Operations · Since at least Nov 5, 2026
Silvia SiegfriedSenior Director, Investor Relations · Since at least Apr 2, 2026
Tamara HacklSenior Director, Investor Relations · Since at least Apr 2, 2026
Ted StueckSenior VP and Chief Ethics, Risk and Compliance Officer · Since at least Nov 5, 2026
Tom OcchipintiSenior VP, Head of US Biosimilar · Since at least Nov 5, 2026
Yannis SkoufalosBoard member · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about Sandoz Group Ltd.